Weight-related teasing from family members is common among adolescents, and new research from UConn's Rudd Center for Food Policy & Health shows that who the teasing comes from may play an important role in youth health and ...
May 1, 2026
0
2
Consumption of ultra-processed foods—including soft drinks, snacks and ready meals—is growing worldwide, despite evidence they are unhealthy.
May 1, 2026
0
7
New research has shown that GLP‑1 weight-loss drugs deliver protection against heart attacks, strokes, and premature death over a sustained period of time. Researchers from Anglia Ruskin University (ARU) analyzed data from ...
Apr 30, 2026
0
10
A new randomized clinical trial provides some of the clearest evidence to date that what we eat can meaningfully reshape both human health and the health of the planet. Researchers have found that a low-fat vegan diet reduced ...
Apr 30, 2026
0
13
The study, published in Nature Medicine, shows that future risk of 18 obesity-related diseases can be predicted using 20 commonly collected health measures, such as blood test results and demographic information. The tool ...
Apr 30, 2026
0
9
A Mayo Clinic study has found that both metabolic and bariatric surgery and GLP-1 medications improve cardiovascular health in people with obesity, but surgery was associated with significantly greater reductions in long-term ...
Apr 28, 2026
0
5
Keeping tabs on blood sugar throughout the day used to be the exclusive domain of people with diabetes. But in 2026, anyone can buy a user-friendly wearable device that provides minute-by-minute readouts on how their glucose ...
Apr 28, 2026
0
3
The Centers for Medicare & Medicaid Services (CMS) has announced that its temporary program to cover GLP-1 drugs for obesity in Medicare, called the BALANCE model, will not launch as scheduled on Jan. 1, 2027.
Apr 27, 2026
0
10
In a new study, researchers found that older adults with obesity had significantly decreased measures of lung function compared to those without obesity, and the results were consistent among men and women. These results ...
Apr 27, 2026
0
3
Glucagon-like peptide-1 receptor agonists, known as GLP-1 drugs, are highly effective at helping people lose weight and substantially lower the risk of heart attacks, strokes, and death from heart disease. A new study conducted ...
Apr 27, 2026
0
3
